Pamela Esposito

Insider Reports History

Entity
Individual
Location
C/O Replimune Group, Inc., 18 Commerce Way, Woburn, Massachusetts
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pamela Esposito:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Chief Business Officer Common Stock 263K $2.88M $10.92 Sep 12, 2023 Direct
Replimune Group, Inc. Chief Business Officer Employee Stock Option (right to buy) 86K Sep 12, 2023 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 16K Jun 18, 2024 Direct

Insider Reports Filed by Pamela Esposito

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
REPL Replimune Group, Inc. Sep 11, 2023 6 -$94.5K 4 Sep 13, 2023 Chief Business Officer
REPL Replimune Group, Inc. Aug 22, 2023 5 -$250K 4 Aug 24, 2023 Chief Business Officer
REPL Replimune Group, Inc. Aug 11, 2023 3 -$23.4K 4 Aug 15, 2023 Chief Business Officer
REPL Replimune Group, Inc. Jul 10, 2023 6 -$305K 4 Jul 11, 2023 Chief Business Officer
KYMR Kymera Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
REPL Replimune Group, Inc. May 16, 2023 1 -$108K 4 May 18, 2023 Chief Business Officer
REPL Replimune Group, Inc. Apr 1, 2023 2 $0 4 Apr 4, 2023 Chief Business Officer
REPL Replimune Group, Inc. Dec 9, 2022 3 -$360K 4 Dec 13, 2022 Chief Business Officer
KYMR Kymera Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
REPL Replimune Group, Inc. May 16, 2022 1 -$51.2K 4 May 18, 2022 Chief Business Officer
REPL Replimune Group, Inc. Apr 1, 2022 2 $0 4 Apr 5, 2022 Chief Business Officer
REPL Replimune Group, Inc. Aug 4, 2021 6 -$587K 4 Aug 6, 2021 Chief Business Officer
REPL Replimune Group, Inc. Jul 20, 2021 6 -$559K 4 Jul 22, 2021 Chief Business Officer
REPL Replimune Group, Inc. Jul 15, 2021 3 -$149K 4 Jul 19, 2021 Chief Business Officer
KYMR Kymera Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
REPL Replimune Group, Inc. Jan 14, 2021 10 -$2.36M 4/A Jul 19, 2021 Chief Business Officer